Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannaflower is a premier producer and distributor of high-quality craft hemp flower and CBD products, formerly known as Berkshire CBD. The company specializes in sun-grown, organic hemp that is cultivated for high terpene and cannabinoid content to support therapeutic wellness. Their product portfolio includes a wide variety of hemp strains available as whole flower, pre-rolls, and specialized CBD oils. Cannaflower emphasizes transparency through rigorous third-party lab testing and certificates of analysis for all products. Based in the United States, the company serves both the direct-to-consumer market and wholesale distributors within the legal hemp industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannaflower.